Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma

Japanese Journal of Clinical Oncology

Volumn 37, Issue 9, 2007, Pages 652-657

  Gotoh, Masahiro ^a   Takiuchi, Hiroya ^a   Kawabe, Shin Ichiro ^a   Ohta, Shunsuke ^a   Kii, Takayuki ^a   Kuwakado, Shin ^a   Katsu, Ken Ichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Chemoradiotherapy; Epidermal growth factor receptor; Esophageal cancer

Indexed keywords

CISPLATIN; CYCLIN D1; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EFFECTIVENESS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PROTEIN EXPRESSION; REVIEW; SURVIVAL TIME; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, ADJUVANT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 35448936111     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym089     Document Type: Review

References (22)

1. Roth JA, Putnam JB, Jr. Surgery for cancer of the esophagus. Semin Oncol 1994;21(4):453-61.
2. Brenner B, Ilson DH, Minsky BD. Treatment of localized esophageal cancer. Semin Oncol 2004;31(4):554-65.
3. Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radial Oncol Biol Phys 2003;57(2):425-33.
4. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17(9):2915-21.
5. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005;23(10):2310-7.
6. Bedenne I.P.M, Bóuche O, Triboulet J-P, Conroy T, Pezet D, Roullet B, Seitz J-F, Lacourt J, Milan C, Service d'Hepato, Gastroenterologie, Chu, Le Bocage, Dijon Cedex, France, CHU Charles-Nicolle, Rouen France; CHU Robert-Debre, Reims, France; CHU Claude-Huriez, Lille, France; Centre Alexis Vautrin, Nancy, France; CHU Hotel-Dieu, Clermont-Ferrand, France; CHU Dupuytren, Limoges, France; CHU la Timone, Marseille, France; Clinique Sainte-Marie, Chalon sur Saone, France; FFCD Statistical Center, Dijon, France. Randomized phase III trial in locally advanced esophageal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Clin Oncol 2002;21: 130a.
7. Bonnetain F, Bouche O, Michel P, Mariette C, Conroy T, Pozet D, et al. A comparative longitudinal quality of lifd-study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006; 17(5):827-34.
8. Ozawa S, Ueda M, Ando N, Shimizu N, Abe O. Prognostic significance of epidermal growth, factor receptor in esophageal squamous cell carcinomas. Cancer 1989;63(11):2169-73.
9. Mukaida H, Toi M, Hirai T, Yamashita Y, Toge T. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer. Cancer 1991;68(1):142-8.
10. Itakura Y, Sasano H, Shiga C, Furukawa Y, Shiga K, Mori S, et al. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer 1994;74(3):795-804.
11. Kitagawa Y, Ueda, M, Ando N, Ozawa S, Shimizu N, Kitajima M. Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Clin Cancer Res 1996;2(5):909-14.
12. Tahara M, Ohtsu A, Hironaka S, Boku N, Ishikura S, Miyata Y, et al. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer. Jpn J Clin Oncol 2005;35(6):316-23.
13. Yano H, Shiozaki H, Kobayashi K, Yano T, Tahara H, Tamura S, et al. Immunohistologic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma. Cancer 1991;67(1):91-8.
14. Gibault L, Metges JP, Conan-Charlet V, Lozac'h P, Robaszkiewicz M, Bessaguet C, et al. Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous' cell cancer, Br J Cancer 2005;93(1):107-15.
15. Boku N, Chin K, Hosokawa K, Ohtsu A, Tajiri H, Yoshida S, et al. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum. Clin Cancer Res 1998;4(6):1469-74.
16. Samejima R, Kitajima Y, Yunotani S, Miyazaki K. Cyclin DI is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma. Anticancer Res 1999;19(6C):5515-21.
17. Jain S, Filipe MI, Hall PA, Waseem N, Lane DP, Levison DA. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991;44(8):655-9.
18. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. New Engl J Med 1996;335(7):462-7
19. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. New Engl J Med 1997;337(3):161-7.
20. Urba SG, Orringer M-B, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19(2):305-13.
21. Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao,Z, Komaki R, et al. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 2005; 104(11):2365-72.
22. Chapman JD, Dugle DL, Reuvers, AP, Meeker BE, Borsa J. Letter: Studies on the radiosensitizing effect of oxygen in Chinese hamster cells. Int J Radiat Biol Relat Stud Phys Chem Med 1974;26(4):383-9.